SCHEMBL6552035

SCHEMBL6552035

CCn1c(C(=O)OC)nc(-c2ccc(Cl)cc2)c1-c1ccc(Cl)cc1Cl

nearest known ligand 0.56

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
CNR1 P21554 13/20 0.56
OPRL1 P41146 2/20 0.45
DPP4 P27487 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7041801 0.92 CNR1 (0.56) CNR1OPRL1DPP4
SCHEMBL7044616 0.91 CNR1 (0.66) CNR1OPRL1
SCHEMBL4080145 0.90 CNR1 (0.52) CNR1DPP4
SCHEMBL7045699 0.81 CNR1 (0.62) CNR1OPRL1DPP4
SCHEMBL4079594 0.81 CNR1 (0.77) CNR1
SCHEMBL4075955 0.81 CNR1 (0.66) CNR1
SCHEMBL4076187 0.80 CNR1 (0.86) CNR1OPRL1
SCHEMBL7043322 0.78 CNR1 (0.61) CNR1OPRL1
SCHEMBL4080087 0.78 CNR1 (0.59) CNR1OPRL1DPP4
SCHEMBL7044993 0.76 CNR1 (0.44) CNR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2003007887-A2 SUBSTITUTED IMIDAZOLES AS CANNABINOID RECEPTOR MODULATORS MERCK & CO., INC. (US) 2003-01-30 WO claimed
EP-1482794-A1 METHOD OF TREATMENT OR PREVENTION OF OBESITY Merck & Co., Inc. (US) 2004-12-08 EP disclosed
WO-2003075660-A1 METHOD OF TREATMENT OR PREVENTION OF OBESITY MERCK & CO., INC. (US) 2003-09-18 WO disclosed
WO-2003007887-A2 SUBSTITUTED IMIDAZOLES AS CANNABINOID RECEPTOR MODULATORS MERCK & CO., INC. (US) 2003-01-30 WO disclosed